TipRanks
Go Ultimate55% OFF

Vasamed (VSMD) Financial Statements

Vasamed Financial Overview

Vasamed's market cap is currently $8. The company's EPS TTM is ―; its P/E ratio is 0.00; Vasamed has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 05Dec 04Dec 03Dec 02Dec 01
Income Statement
Total Revenue―――――
Gross Profit$ -69.39K$ -318.16K$ 315.95K$ 1.15M―
Operating Income$ -4.74M$ -6.29M$ -2.29M$ -1.88M$ -2.73M
EBITDA$ -4.59M$ -6.09M$ -2.20M$ -1.74M$ -2.40M
Net Income$ -4.89M$ -6.42M$ -2.28M$ -1.85M$ -3.40M
Balance Sheet
Cash & Short-Term Investments―――――
Total Assets$ 1.60M$ 1.02M$ 1.69M$ 2.62M$ 2.16M
Total Debt$ 23.45K$ 0.00$ 0.00$ 0.00$ 1.49M
Net Debt$ 22.12K$ -8.76K$ -17.32K$ -243.75K$ 824.43K
Total Liabilities$ 1.01M$ 4.72M$ 610.45K$ 2.91M$ 2.35M
Stockholders' Equity―――――
Cash Flow
Free Cash Flow$ -4.91M$ -4.04M$ -1.75M$ -2.42M$ -1.21M
Operating Cash Flow―――――
Investing Cash Flow―――――
Financing Cash Flow―――――

Currency in USD